Search This Blog

Monday, May 4, 2020

Rhythm Pharmaceuticals EPS beats by $0.02

Rhythm Pharmaceuticals (NASDAQ:RYTM): Q1 GAAP EPS of -$0.78 beats by $0.02.
Cash, cash equivalents and short-term investments of $257.4M
https://seekingalpha.com/news/3568190-rhythm-pharmaceuticals-eps-beats-0_02

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.